Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model

Pancreas

Volumn 37, Issue 4, 2008, Pages 440-444

  Guimaraes, Alexander R ^a   Rakhlin, Elena ^a   Weissleder, Ralph ^a   Thayer, Sarah P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Magnetic resonance imaging; Nanoparticle; Pancreatic cancer; Sonic hedgehog

Indexed keywords

5E1 ANTIBODY; CYCLOPAMINE; FORSKOLIN; IRON OXIDE; NANOPARTICLE; PROTEIN ANTIBODY; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; ANTIBODY; CONTRAST MEDIUM; MAGNETITE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; SHH PROTEIN, HUMAN; VERATRUM ALKALOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINEAR REGRESSION ANALYSIS; MICROVESSEL DENSITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PHYSIOLOGY; PRIORITY JOURNAL; PROLIFERATIVE INDEX; TREATMENT RESPONSE; TUMOR XENOGRAFT; VASCULAR VOLUME FRACTION; VIABLE GLAND DENSITY; ANIMAL; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES; CARCINOMA, PANCREATIC DUCTAL; CELL PROLIFERATION; CONTRAST MEDIA; FERROSOFERRIC OXIDE; FORSKOLIN; HEDGEHOG PROTEINS; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION; VERATRUM ALKALOIDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 58149175893     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31817c5113     Document Type: Article

References (31)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 2000;50:7-33.
2. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237(1):74-85.
3. Lim JE, Chein MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma. Ann Surg. 2003;238(1):74-85.
4. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68-72.
5. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database (see comments). J Am Coll Surg. 1999;189:1-7.
6. Yeo CJ, Cameron JL, Sohn TA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999;229(5):613-631.
7. Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363(9414): 1049-1057.
8. Mimeault M, Brand RE, Sasson AA, et al. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas. 2005;31(4):301-316.
9. Postier RG. The challenge of pancreatic cancer. Am J Surg. 2003; 186(6):579-582.
10. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2(12):897-909.
11. Friess H, Ding J, Kleeff J, et al. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci. 2003;60(6):1180-1199.
12. Holzmann K, Kohlhammer H, Schwaenen C, et al. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res. 2004;64(13):4428- 4433.
13. Joyce JA, Laakkonen P, Bernasconi M, et al. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 2003;4(5):393-403.
14. Missiaglia E, Blaveri E, Terris B, et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer. 2004;112(1):100-112.
15. Ohno K, Hata F, Nishimori H, et al. Metastatic-associated biological properties and differential gene expression profiles in established highly liver and peritoneal metastatic cell lines of human pancreatic cancer. J Exp Clin Cancer Res. 2003;22(4):623-631.
16. Saad ED, Hoff PM. Molecular-targeted agents in pancreatic cancer. Cancer Control. 2004;11(1):32-38.
17. Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev. 2000;26(1):29-52.
18. Shi X, Liu S, Kleeff J, et al. Acquired resistance of pancreatic cancer cells towards 5-fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology. 2002;62(4): 354-362.
19. Trauzold A, Schmiedel S, Oestern S, et al. Concerted deregulations of multiple apoptosis-controlling genes in pancreatic carcinoma cells. Ann N Y Acad Sci. 2003;1010:510-513.
20. Thayer S. The emerging role of the hedgehog signaling pathway in gastrointestinal cancers. Clin Adv Hematol Oncol. 2004;2(1):17-63.
21. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature. 2003;425 (6960):851-856.
22. Kayed H, Kleeff J, Keleg S, et al. Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer. Int J Cancer. 2004; 110(5):668-676.
23. Kayed H, Kleeff J, Osman T, et al. Hedgehog signaling in the normal and diseased pancreas. Pancreas. 2006;32(2):119-129.
24. Xie K, Abbruzzese JL. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell. 2003;4(4):245-247.
25. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A. 2007;104(12):5103-5108.
26. Asai J, Takenaka H, Kusano KF, et al. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation. 2006;113(20):2413- 2424.
27. Donahue JK. Gene therapy, angiogenesis, Sonic Hedgehog: Sonic the Hedgehog to the rescue? Gene Ther. 2006;13(13):998-999.
28. Bremer C, Mustafa M, Bogdanov A Jr, et al. Steady-state blood volume measurements in Experimental tumors with different angiogenic burdens-a study in mice. Radiology. 2003;226(1):214-220.
29. Tang Y, Kim M, Carrasco D, et al. In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging. Cancer Res. 2005;65(18):8324-8330.
30. Boxerman J, Hamberg L, Rosen B, et al. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med. 1995;34:555-566.
31. Dennie J, Mandeville J, Boxerman J, et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med. 1998;40:793-799.